In a dynamic and demanding market like Peru, where access to high-quality pharmaceutical products is a matter of public health, D & M Pharma Peru SAC stands as a reliable and strategic partner. With a firm commitment to safety, efficacy, and regulatory compliance, the company has carved out a reputation for excellence in the distribution and commercialization of pharmaceutical and healthcare supplies.
D amp M Pharma Peru SAC is officially registered as a "Sociedad Anónima Cerrada" (SAC) – a closed corporation under Peruvian law. This legal designation indicates a private entity with a limited number of shareholders, often family-owned or operated by a small group of investors. The "SAC" suffix is common among mid-sized Peruvian firms that prioritize agility and direct control over public trading.
The "D amp M" in the name typically denotes the founding partners or core principles (e.g., "Development and Marketing" or the initials of the founders), though public records suggest a focus on pharmaceutical distribution and specialized medical supplies. Unlike generic drugstore chains, D amp M Pharma Peru SAC positions itself as a B2B wholesaler and institutional supplier, working directly with clinics, pharmacies, and government health programs.
D amp M Pharma Peru SAC stands as a testament to the specialized, compliance-driven segment of Peru’s pharmaceutical distribution industry. By focusing on institutional supply, cold chain integrity, and regulatory rigor, the company fills a vital role that retail giants and import-only firms cannot easily replicate.
For international suppliers, partnering with D amp M Pharma Peru SAC offers a gateway to Peru’s growing healthcare market. For local clinics and hospitals, the company provides reliability in a sector where product quality can be a matter of life and death. As Peru continues to modernize its healthcare system, expect this name to appear more frequently in tender announcements and industry directories.
Disclaimer: This article is for informational purposes only. Always verify current licensing and status with Peruvian regulatory authorities (DIGEMID, SUNARP) before engaging in any commercial transaction. The author does not claim any affiliation with D amp M Pharma Peru SAC.
D&M Pharma Peru S.A.C. (also known as D&M Pharma or DYM) is a pharmaceutical company based in Lima, Peru, that specializes in the commercialization and marketing of health products. Established in 2007, the company is a strategic partner of Argentina’s Laboratorio Cassará and focuses on providing accessible, high-quality respiratory and general health solutions.
The following guide outlines the company's core operations, regulatory environment, and contact channels. 1. Company Profile & Mission d amp m pharma peru sac
Core Focus: D&M Pharma operates in the wholesale of non-durable goods, specifically pharmaceutical products.
Partnership: It serves as the local representative and strategic ally for the renowned Laboratorio Cassará from Argentina, distributing their product lines in the Peruvian market.
Mission: Their stated objective is to support the medical community and provide patients with safe, effective, and ethical treatments, particularly for respiratory health. 2. Operational & Regulatory Standards
To maintain its position in the pharmaceutical industry, D&M Pharma Peru adheres to strict local and international standards:
Regulatory Compliance: The company follows the BPA (Buenas Prácticas de Almacenamiento)—Good Storage Practices—as mandated by Peruvian health authorities.
Quality Assurance: Their technical leadership actively participates in national industry bodies, such as the Lima Chamber of Commerce (COMSALUD), ensuring alignment with modern health regulations.
Pharmacovigilance: D&M maintains a dedicated system for monitoring the safety and efficacy of its products once they are on the market. 3. Key Product Segments D & M Pharma Peru SAC: Committed to
While specific catalogs are often reserved for medical professionals, their presence typically spans:
Respiratory Health: Specialized treatments for asthma and other pulmonary conditions (linked to the Cassará expertise).
Miscellaneous Pharmaceuticals: A variety of ethical and over-the-counter (OTC) products intended for general healthcare. 4. Contact & Support Information
For medical inquiries, pharmacovigilance reports, or commercial inquiries, you can reach the company through their official website:
Main Office: Av. Pablo Carriquiry 660, Piso 3, San Borja, Lima, Peru. General Phone: +51 1 2216662.
Pharmacovigilance Email: farmacovigilancia@dympharmaperu.com.
Social Channels: Professional updates and corporate news are frequently posted on the D&M Pharma Perú LinkedIn page. D & M Pharma Peru S.A.C. Company Profile - EMIS Disclaimer: This article is for informational purposes only
The Peruvian pharmaceutical distribution market is moderately concentrated, with major players like Farmacias Peruanas, MiFarma, and Corbeta dominating retail. However, D amp M Pharma Peru SAC occupies a valuable niche: institutional and sub-distribution.
Unlike retail giants, D amp M Pharma Peru SAC does not typically own storefront pharmacies. Instead, it acts as a secondary wholesaler or specialized logistics provider for:
This model reduces overhead while allowing the company to serve hard-to-reach areas where major distributors have thin coverage.
Any pharmaceutical entity operating in Peru must adhere to the strict oversight of the Dirección General de Medicamentos, Insumos y Drogas (DIGEMID) – the country’s equivalent of the FDA. D amp M Pharma Peru SAC’s operational legitimacy hinges on maintaining current Good Distribution Practices (GDP) and Good Storage Practices (GSP) certifications.
According to publicly available DIGEMID registries, D amp M Pharma Peru SAC holds authorization for the following activities:
The company’s compliance record is a key differentiator in an industry where counterfeit or mishandled drugs remain a concern in certain Latin American markets. By maintaining ISO and local health authority standards, D amp M Pharma Peru SAC assures partners of product integrity from port of entry to point of dispensation.